Minerva Neurosciences Inc (NASDAQ:NERV)
| 3.54 Delayed Data As of Sep 18 |  +0.04 / +1.14%Today’s Change | 1.81 Today|||52-Week Range 15.22 | -50.21% Year-to-Date |
Latest NERV News | Press Releases
No recent news for Minerva Neurosciences Inc.
Today’s Trading
| Previous close | 3.50 |
| Today’s open | 3.47 |
| Day’s range | 3.37 - 3.55 |
| Volume | 53,587 |
| Average volume (3 months) | 2,747,803 |
| Market cap | $117.8M |
Data as of 3:59pm ET, 09/18/2020
Growth & Valuation
| Earnings growth (last year) | -43.06% |
| Earnings growth (this year) | +99.24% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.02 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SESNSesen Bio Inc | +0.14 | +12.39% |
| GNPXGenprex Inc | -0.06 | -1.55% |
| ZSANZosano Pharma Corp | +0.01 | +0.56% |
| ACRXAcelRx Pharmaceutica... | +0.21 | +15.33% |
Data as of 3:59pm ET, 09/18/2020
Financials
| Next reporting date | November 9, 2020 |
| EPS forecast (this quarter) | -$0.23 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$72.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
